New weapon to combat resistant bacteriaDecember 10, 2003The problem of hospital infection, severe disease caused by antibiotic-resistant staphylococcus bacteria, entails major costs and great suffering. Group A streptococcus bacteria, also called meat-eating killer bacteria, are another growing problem. A team of Lund scientists in Sweden has now developed a substance called Cystapep, which seems to work on bacteria that nothing else seems to be able to knock out. If Cystapep delivers what it promises, this is nothing short of sensational. Sweden is in a better position than other countries when it comes to antibiotic resistance, but in other parts of the world dangerous strains of bacteria have developed resistance to most of the antibiotics doctors have in their arsenal, and the problem is growing worse every year in Sweden as well. The name Cystapep is based on the fact that the new substance is a peptide derivative from a larger larger protein called cystatin. Cystatin occurs in various forms in the body and is part of our natural protection against bacteria, fungi, and viruses. The Lund researchers Aftab Jasir and Claes Schalén, medical microbiology, and Anders Grubb, clinical chemistry, have collaborated with a team of Polish scientists to synthesize a peptide based on the inhibitory centre of human cystatin C. "The substance has been shown to be effective against infectious staphylococci, streptococci, enterococci, and pneumococci bacteria, which include many dangerous and more or less antibiotic-resistant strains. On the other hand, the body's own flora of bacteria is not affected, which is good news," says Aftab Jasir. Cystapep has also been shown to attack polio and herpes viruses. The fact that one and the same substance works against not only infectious bacteria but also viruses is unique. And the substance seems to have its very own modus operandi that bacteria cannot easily defend themselves against. The Lund team has tried to induce resistance to Cystapep by creating mutations, a procedure that is usually not very difficult, but it didn't work at all in this case. The researchers have just published their findings in APMIS, Acta Patologica Microbiologica Immunologica Scandinavica. Before transferring an eventual patent to the pharmaceuticals industry, they want to learn more about the way the substance works, try to make it even more effective, and try out its efficacy against foreign strains of bacteria. Since Aftab Jasir and Claes Schalén are the project leader and coordinator, respectively, of a major EU project on Group A-streptococci, they have ready access to bacteria cultures from other countries. Clinical use of the substance may become a reality in 5 to 10 years' time. | |||||||||||||||||||||
|
Related Bacteria Current Events and Bacteria News Articles Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. Blood tests can help detect presence of necrotizing soft tissue infections With less than half of patients with necrotizing soft tissue infections displaying the physical signs of these very serious infections, researchers have found two simple blood tests can help physicians diagnose what is commonly known as "flesh-eating bacteria," according to a study in the December issue of The American Journal of Surgery. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems. But, a new theory actually hopes to take stopping infectious diseases such as West Nile virus and Malaria to the next level by disabling insects from transmitting these viruses. Research in twins defines shared features of the human gut microbial communities: variations linked to obesity Trillions of microbes make their home in the gut, where they help to break down and extract energy and nutrients from the food we eat. Yet, scientists have understood little about how this distinctive mix of microbes varies from one individual to the next. Rivers are carbon processors, not inert pipelines Microorganisms in rivers and streams play a crucial role in the global carbon cycle that has not previously been considered. Vitamin D found to fight placental infection In a paper available at the online site of the journal Biology of Reproduction, a team of UCLA researchers reports for the first time that vitamin D induces immune responses in placental tissues by stimulating production of the antimicrobial protein cathelicidin. CSHL scientists discover a new way in which epigenetic information is inherited Hereditary information flows from parents to offspring not just through DNA but also through the millions of proteins and other molecules that cling to it. Researchers identify how binge drinking may drive heart disease As the holidays arrive, a group of researchers has identified the precise mechanisms by which binge drinking contributes to clogs in arteries that lead to heart attack and stroke, according to a study published today in the journal Atherosclerosis. Researchers identify new leprosy bacterium A new species of bacterium that causes leprosy has been identified through intensive genetic analysis of a pair of lethal infections, a research team reports in the December issue of the American Journal of Clinical Pathology. More Bacteria Current Events and Bacteria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||